Long-Term Care Facilities, Pharmaceuticals and Pharmacy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Long-Term Care Facilities

Pharmaceuticals

Pharmacy

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

The Pharma Data

NOVEMBER 8, 2020

PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. At some hospitals, it can take up to 30 minutes to get a status epilepticus drug from the pharmacy to the point of care in the ER to treat a patient. About Sedor Pharmaceuticals, LLC. About Sesquient.

FDA Approval

FDA Approval FDA Long-Term Care Facilities Treatment

‘Warp Speed’ Officials Say U.S. COVID Vaccine Distribution Too Slow

The Pharma Data

DECEMBER 31, 2020

According to the Times , he said that health care facilities are still learning how to store the vaccines at super-low temperatures, and many states are setting aside doses for use at long-term care facilities, an effort that’s expected to take several months. A global scourge. By Thursday, the U.S.

Vaccine

Vaccine Long-Term Care Facilities Virus Hospitals

Drug Discovery Digest

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

‘Warp Speed’ Officials Say U.S. COVID Vaccine Distribution Too Slow

Stay Connected